SUMMARY Clinical and electrocardiographic findings for 30 patients with the pre-excitation syndrome are described together with details of treatment. Nineteen (63 %) were younger than 2 years, 14 of whom were under 2 months. Sixteen Pre-excitation during infancy and childhood is often associated with rapid tachyarrhythmias causing significant morbidity.f8 The large spectrum of pharmacological agents used to stop such arrhythmias is a reflection of the lack of optimal therapy.
The term 'pre-excitation' is often used when two conduction pathways between atria and ventricles are encountered. These connections: the AV nodalHis pathway and the accessory pathway-have various electrocardiographic expressions. The most common form was described first by Wolff et al., ' and is characterised by a short PR interval, delta waves, and prolonged QRS duration. Various other electrocardiographic combinations-such as a short PR interval, normal QRS duration with or without delta waves as in the Lown-Ganong-Levine (LGL) syndrome2-also occur.
Pre-excitation during infancy and childhood is often associated with rapid tachyarrhythmias causing significant morbidity.f8 The large spectrum of pharmacological agents used to stop such arrhythmias is a reflection of the lack of optimal therapy.
The clinical and electrocardiographic findings on 30 patients with the pre-excitation syndrome are described. Those With congenital heart disease 2 indicating antegrade conduction via the AV node, and were wide in 2 patients indicating antegrade conduction via the accessory pathway. Four patients with WPW syndrome and PSVT had congenital cardiac anomalies (Table 1) . One of them (Case 4) at age 4 years underwent a pacemaker implantation after complete heart block. Before this episode, repeated bouts of PSVT, ventricular tachycardia, and fibrillation were noted. Tachyarrhythmias were initially controlled by a continuous infusion of verapamil which was later changed to oral amiodarone.
Asymptomatic
Seven patients were diagnosed after a physical examination for a cardiac murmur. Two of them had congenital heart disease ( Table 1) . Two patients had type A and 4 type B WPW syndrome, and one The recent introduction of oral amiodarone has led to the control of arrhythmias as in adults.16 17 The right choice of treatment in patients with WPW syndrome and recurrent tachyarrhythmias is important and the following facts must be borne in mind: (1) Most attacks occur in infants who are likely to develop cardiac failure, and immediate termination of the arrhythmia is imperative. ( 2) The use of drugs in order to convert the arrhythmia in these young infants must be safe with a wide margin between the therapeutic and toxic dosages. ( 3) The effect of medication on the accessory pathways must also be taken into consideration. 
